Streetbeat News

Products Services

GSK

PFE

The WHO released a report on HIV Drug Resistance, highlighting the effectiveness of dolutegravir (DTG)-containing antiretroviral therapy but also raising concerns about increasing drug resistance. ViiV Healthcare, backed by GSK and Pfizer, sells DTG under various names. The report emphasizes the need for routine surveillance to manage drug resistance and improve patient care. ViiV's phase I study of cabotegravir ultra long-acting shows promise for extended dosing intervals for HIV treatment and prevention.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 5:57 pm

BYDDY

NIO

TSLA

XPEV

EV deliveries in China continue to decline, impacting shares of major EV manufacturers. Nio, XPeng, Li Auto, Tesla, and BYD all experienced significant share price drops following the release of February delivery figures by the China Passenger Car Association. Tesla and BYD's shipments decreased, with Tesla hitting its lowest level since December 2022 and BYD since May 2022. Li Auto, despite a YoY rise, saw a month-on-month drop, as did Nio and XPeng. Nio's Q4 results showed widened losses and a disappointing outlook, contrasting with XPeng and Li Auto's profitability. The intense competition and price war in the EV market in China are highlighted.

Portfolio Pulse from Upwallstreet

March 05, 2024 | 5:49 pm

GOOG

GOOGL

TSLA

UBER

A Reddit post discussed Alphabet Inc's Waymo, highlighting its advanced autonomous driving technology and potential for industry dominance. Users shared positive experiences and optimism for Waymo's expansion and its role in Google's AI portfolio. Despite challenges, the sentiment is bullish on Waymo's long-term prospects.

Portfolio Pulse from Surbhi Jain

March 05, 2024 | 5:31 pm

SIDU

Sidus Space Inc. (NASDAQ:SIDU) shares dropped over 15% following the announcement of a successful payload deployment to low Earth orbit with SpaceX's Transporter-10 Rideshare mission and the pricing of an underwritten public offering of 1.32 million shares at $6.00 each for gross proceeds of approximately $7.9 million. The funds are intended for working capital and general corporate purposes, with the offering expected to close on March 5, 2024. The launch of LizzieSat marks a significant milestone for Sidus Space in space technology and data services.

Portfolio Pulse from Nabaparna Bhattacharya

March 05, 2024 | 5:29 pm

MDB

MongoDB, Inc. (NASDAQ:MDB) shares have declined over 10% in the past five days, attributed to Nasdaq's weakness. Despite this, MongoDB's stock has surged over 80% in the past year, driven by the growing adoption of artificial intelligence and the expansion of its Atlas data platform to new cloud regions. Guggenheim maintains a Sell rating but raised its price target from $250 to $272. MongoDB is expected to report Q4 earnings of 47 cents per share and revenue of $433.831 million. The company's long-term stock performance suggests a potential future price of $1771.85.

Portfolio Pulse from Erica Kollmann

March 05, 2024 | 5:25 pm

META

Meta's spokesperson Andy Stone announced that the company has resolved the issue affecting users' access to some of Meta's services, as reported by Reuters.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 5:23 pm

BCLI

Brainstorm Cell Therapeutics has received Israeli Patent Number 277447 for 'Cell-Type Specific Exosomes And Use Thereof' aimed at treating neurodegenerative diseases. This development could enhance the company's intellectual property portfolio and potentially impact its research and development in neurodegenerative disease treatments.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 5:17 pm

DOGEUSD

SHIBUSD

SOLUSD

'BONK Killer' MILLI, operating on the SEI network, surged over 70% in a single day, outperforming other meme cryptocurrencies like Dogecoin, Shiba Inu, and BONK. MILLI's market cap approached $2.5 million with a trading volume of $522,075. The token's success is attributed to strong community support and a unique brand identity. Meanwhile, Dogecoin and BONK saw declines, while Shiba Inu increased by 6%. The MILLI team also addressed investor concerns, aiming to restore token distribution and liquidity.

Portfolio Pulse from Mehab Qureshi

March 05, 2024 | 5:16 pm

OWPC

One World Products Inc (OTCQB:OWPC) launched Pro-11, a CBD-enriched muscle rub, during the 2024 NBA All-Star Weekend. This product is a collaboration between Kx Family Care, led by Stephen Marley, and guided by NBA Hall of Famer Isiah Thomas. Kx Family Care made a strategic investment of $400,000 in OWP to boost its operations in Colombia's Bogota Free Trade Zone. Pro-11 is designed for athletes, combining CBD, essential oils, and natural extracts for optimal performance and recovery. It will be available on March 15, 2024, and is expected in select retail locations later that year. OWPC's shares were up 18.60% at $0.0593 per share.

Portfolio Pulse from Patricio Liddle

March 05, 2024 | 5:11 pm

RGNX

REGENXBIO Inc (NASDAQ:RGNX) reported positive interim safety and efficacy data from the Phase 1/2 AFFINITY DUCHENNE trial of RGX-202 for Duchenne muscular dystrophy in patients aged 4 to 11 years. The drug was well tolerated with no serious adverse events, and showed promising results in microdystrophin expression and reduction in serum creatinine kinase levels, indicating potential clinical improvement. The company plans to make a pivotal dose determination in mid-2024 and expects to initiate a pivotal trial in the second half of 2024, aiming for accelerated approval. RGNX shares surged 17.90% to $25.34.

Portfolio Pulse from Vandana Singh

March 05, 2024 | 5:07 pm